Toronto, Canada

Clifford A Lingwood

This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: Hsc Research and Development Limited Partnership, The Hospital for Sick Children, Hospital for Sick Children Research and Development Limited Partnership. Active years: 1986-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clifford A Lingwood. Retrieved from https://idiyas.com/inventor/clifford-a-lingwood

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 72.2

 

 

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 72(Granted Patents)


Location History:

  • Etobicoke, CA (1992)
  • Toronto, CA (1986 - 2018)

Company Filing History:


Years Active: 1986-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Holotoxin
Lysosomal Disorders
Verotoxin
Intracellular Targeting
Glycolipid Mimics
Haemophilus Adhesin Protein
Microbial Colonization
Verocytotoxin
Antidigoxin Antibodies
Phospholipids
Hydrocarbon Coupling
Medical Treatments
18 patents (USPTO):Explore Patents

Title: **Clifford A. Lingwood: A Noteworthy Innovator in Protein Misfolding Disorders**

Introduction

Clifford A. Lingwood is a distinguished inventor based in Toronto, Canada, recognized for his significant contributions to the field of biomedical research. He holds 18 patents that reflect his commitment to developing innovative solutions for complex medical challenges, particularly involving protein misfolding and lysosomal disorders.

Latest Patents

Among his recent innovations, Clifford's latest patents include:

1. **Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins.** This invention describes a method to block the degradation of functional yet misfolded proteins within the endoplasmic reticulum, presenting new therapeutic avenues for related diseases.

2. **Compositions and methods for treating lysosomal disorders.** This patent outlines new compositions and methodologies employing substituted imidazole derivatives or compounds aimed at treating lysosomal disorders, indicative of his focus on genetic and metabolic disease solutions.

Career Highlights

Clifford's professional journey features pivotal roles at notable institutions such as HSC Research and Development Limited Partnership, where he engaged in research focused on innovative healthcare solutions, and The Hospital for Sick Children, one of the leading pediatric hospitals in Canada, known for its commitment to advancing child health.

Collaborations

Throughout his career, Clifford has collaborated with esteemed colleagues, including Richard C. Hill and Sara Arab. These partnerships have fostered a collaborative environment that drives innovation and enhances research output in complex biomedical fields.

Conclusion

Clifford A. Lingwood stands out as a prominent inventor whose work in addressing protein misfolding and lysosomal disorders showcases the essence of innovation in healthcare. His contributions through patents not only reflect his expertise but also his dedication to improving patient outcomes in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…